{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:00:16Z","timestamp":1769508016940,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPD1D0293"],"award-info":[{"award-number":["CMRPD1D0293"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chang Gung University Healthy Ageing Research Center","award":["EMRPD1F0251"],"award-info":[{"award-number":["EMRPD1F0251"]}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST104-2320-B-182-009"],"award-info":[{"award-number":["MOST104-2320-B-182-009"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbr.2020.112925","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T13:01:07Z","timestamp":1600693267000},"page":"112925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response"],"prefix":"10.1016","volume":"396","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0580-891X","authenticated-orcid":false,"given":"I-Mei","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2020.112925_bib0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.conb.2013.01.002","article-title":"Unbalanced neural circuits in addiction","volume":"23","author":"Volkow","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbr.2020.112925_bib0010","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1523\/JNEUROSCI.22-09-03312.2002","article-title":"Psychomotor stimulant addiction: a neural systems perspective","volume":"22","author":"Everitt","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2020.112925_bib0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0149-7634(97)00020-1","article-title":"Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration","volume":"22","author":"Robinson","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2020.112925_bib0020","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.109.001933","article-title":"Drug wanting: behavioral sensitization and relapse to drug seeking behavior","volume":"63","author":"Steketee","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbr.2020.112925_bib0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-0173(91)90007-U","article-title":"Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity","volume":"16","author":"Kalivas","year":"1991","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbr.2020.112925_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00213-009-1707-0","article-title":"Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice","volume":"208","author":"Morice","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112925_bib0035","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0006-3223(02)01489-0","article-title":"Valproate attenuates hyperactive and preservative behaviors in mutant mice with a dysregulated dopamine system","volume":"53","author":"Ralph-Williams","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112925_bib0040","article-title":"Antipsychotic medications for cocaine dependence","volume":"3","author":"Indave","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbr.2020.112925_bib0045","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.116.238501","article-title":"Molecular, behavioral, and physiological consequences of methamphetamine neurotoxicity: implications for treatment","volume":"362","author":"Moszczynska","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2020.112925_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2710","article-title":"Methamphetamine\u2010associated psychosis: clinical presentation, biological basis, and treatment options","author":"Chiang","year":"2019","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.bbr.2020.112925_bib0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.schres.2013.10.009","article-title":"The neurobiology of relapse in schizophrenia","volume":"152","author":"Remington","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbr.2020.112925_bib0060","doi-asserted-by":"crossref","first-page":"e1036","DOI":"10.1038\/tp.2017.6","article-title":"Chemistry-based molecular signature underlying the atypia of clozapine","volume":"7","author":"Cardozo","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112925_bib0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia","volume":"20","author":"Horacek","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2020.112925_bib0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/0269881113515065","article-title":"Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem","volume":"28","author":"Marazziti","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2020.112925_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2013.07.023","article-title":"Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization","volume":"47","author":"Herrera","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112925_bib0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/syn.20576","article-title":"Clozapine inhibits development and expression of nicotine-induced locomotor sensitization in rats","volume":"63","author":"Kayir","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2020.112925_bib0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00210-007-0154-x","article-title":"Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate release in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic","volume":"375","author":"Abekaw","year":"2007","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112925_bib0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.psychres.2008.10.005","article-title":"Effects of clozapine on behavioral sensitization induced by cocaine","volume":"175","author":"Park","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbr.2020.112925_bib0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2011.01.026","article-title":"Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study","volume":"220","author":"Steed","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2020.112925_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112925_bib0105","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4306\/pi.2014.11.4.454","article-title":"Effects of clozapine, haloperidol, and fluoxetine on the reversal of cocaine-induced locomotor sensitization","volume":"11","author":"Cha","year":"2014","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.bbr.2020.112925_bib0110","doi-asserted-by":"crossref","first-page":"RA215","DOI":"10.12659\/MSM.881925","article-title":"Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders","volume":"17","author":"Ptacek","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bbr.2020.112925_bib0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-420118-7.00008-1","article-title":"Dopamine D4 receptors in psychostimulant addiction","volume":"69","author":"Di Ciano","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbr.2020.112925_bib0120","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2174\/1871527314666150529132723","article-title":"Dopamine D4 receptor antagonists for the treatment of cocaine use disorders","volume":"14","author":"Bergman","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.bbr.2020.112925_bib0125","doi-asserted-by":"crossref","first-page":"9550","DOI":"10.1523\/JNEUROSCI.19-21-09550.1999","article-title":"Dopamine D4 receptor-knock-out mice exhibits reduced exploration of novel stimuli","volume":"19","author":"Dulawa","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2020.112925_bib0130","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0022-3565(24)37123-X","article-title":"L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral test","volume":"283","author":"Bristow","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2020.112925_bib0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1300\/J069v12n03_05","article-title":"The epidemiology of the comorbidity of psychiatric and addictive disorders: a critical review","volume":"12","author":"Raskin","year":"1993","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.bbr.2020.112925_bib0140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.neubiorev.2003.08.006","article-title":"Dopamine phenotype and behavior in animal models: in relation to attention deficit hyperactivity disorder","volume":"27","author":"Viggiano","year":"2003","journal-title":"Neurosci. Biobehav. Res."},{"key":"10.1016\/j.bbr.2020.112925_bib0145","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/npp.2011.245","article-title":"Blockade of dopamine D4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats","volume":"37","author":"Yan","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2020.112925_bib0150","first-page":"2128","article-title":"Dopamine receptor D4 promoter hypermethylation increases the risk of drug addiction","volume":"15","author":"Ji","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbr.2020.112925_bib0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1017\/neu.2018.14","article-title":"Individual responses of rodents in modeling of affective disorders and in their treatment: prospective review","volume":"30","author":"Einat","year":"2018","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.bbr.2020.112925_bib0160","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1073\/pnas.98.4.1982","article-title":"Hyperactivity and impaired response habituation in hyperdopaminergic mice","volume":"98","author":"Zhuang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2020.112925_bib0165","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.nbd.2009.10.009","article-title":"D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD","volume":"37","author":"Fan","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2020.112925_bib0170","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0022-3565(24)37092-2","article-title":"Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor","volume":"283","author":"Patel","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2020.112925_bib0175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2005.08.002","article-title":"A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats","volume":"82","author":"Browman","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2020.112925_bib0180","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0269881110387840","article-title":"PD168077, a D4 receptor agonist, reverses object recognition deficits in rats: potential role for D4 receptor mechanisms in improving cognitive dysfunction in schizophrenia","volume":"25","author":"Sood","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2020.112925_bib0185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pnpbp.2018.03.017","article-title":"mTOR signaling in the nucleus accumbens mediates behavioral sensitization to methamphetamine","volume":"86","author":"Huang","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112925_bib0190","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s002130050251","article-title":"Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats","volume":"130","author":"Ito","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112925_bib0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1471-4159.2006.04203.x","article-title":"Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt\/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization","volume":"100","author":"Chen","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2020.112925_bib0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0169-328X(98)00196-X","article-title":"Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats","volume":"61","author":"Meng","year":"1998","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.bbr.2020.112925_bib0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pbb.2017.04.010","article-title":"Neurochemical arguments for the use of dopamine D4 receptor stimulation to improve cognitive impairment associated with schizophrenia","volume":"157","author":"Huang","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2020.112925_bib0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00213-002-1018-1","article-title":"Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions","volume":"161","author":"Zhang","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112925_bib0215","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbr.2020.112925_bib0220","first-page":"313","article-title":"Repeated daily restraint stress induces adaptive behavioral changes in both adult and juvenile mice","volume":"167","author":"Sadler","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbr.2020.112925_bib0225","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00213-010-2068-4","article-title":"D1 and D2 dopamine receptors differentially mediate the activation of phosphorylations in the striatum of amphetamine-sensitized rats","volume":"214","author":"Shi","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.112925_bib0230","first-page":"70","article-title":"Supersensitivity psychosis in a case of clozapine tolerance","volume":"16","author":"Ozcan","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbr.2020.112925_bib0235","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbr.2012.10.009","article-title":"Environmental and behavioral controls of the control of clozapine tolerance: evidence from a novel across-model transfer paradigm","volume":"238","author":"Feng","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2020.112925_bib0240","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0269881116654697","article-title":"Antipsychotic-induced sensitization and tolerance: behavioral characteristics, developmental impacts, and neurobiological mechanisms","volume":"30","author":"Li","year":"2016","journal-title":"J. Psychopharm."},{"key":"10.1016\/j.bbr.2020.112925_bib0245","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neuropharm.2013.05.031","article-title":"Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity","volume":"75","author":"Qin","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2020.112925_bib0250","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pharmthera.2018.06.012","article-title":"Molecular targets of atypical antipsychotics: from mechanism of action to clinical differences","volume":"192","author":"Aringhieri","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbr.2020.112925_bib0255","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.euroneuro.2015.11.006","article-title":"An observational study of clozapine induced sedation and its pharmacological management","volume":"26","author":"Perdigu\u00e9s","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2020.112925_bib0260","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.euroneuro.2020.01.016","article-title":"Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: a mediation model","volume":"33","author":"Dal Santo","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2020.112925_bib0265","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12991-015-0075-x","article-title":"Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey","volume":"14","author":"Anderson","year":"2015","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112925_bib0270","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/365441a0","article-title":"Dopamine D4 receptors elevated in schizophrenia","volume":"365","author":"Seeman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2020.112925_bib0275","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbr.2009.11.037","article-title":"Dopamine D4 receptor modulation of cortical neural network activity and emotional processing: implications for neuropsychiatric disorders","volume":"208","author":"Lauzon","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2020.112925_bib0280","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/sj.mp.4002062","article-title":"The pipeline and future of drug development in schizophrenia","volume":"12","author":"Gray","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112925_bib0285","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.mp.4000729","article-title":"Dopamine receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia","volume":"5","author":"Kaiser","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112925_bib0290","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1360-0443.2003.00621.x","article-title":"Reduced dopamine D4 receptor mRNA expression in lymphocytes of long-term abstinent alcohol and heroin addicts","volume":"99","author":"Czermak","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.bbr.2020.112925_bib0295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/15622975.2011.600297","article-title":"Altered mRNA expression of monoaminergic candidate genes in the blood of children with attention deficit hyperactivity disorder and autism spectrum disorder","volume":"12","author":"Taurines","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112925_bib0300","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.pbb.2012.12.006","article-title":"Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate","volume":"103","author":"Keck","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2020.112925_bib0305","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011940","article-title":"Responses to novelty and vulnerability to cocaine addiction: contribution of a multi-symptomatic animal model","volume":"2","author":"Belin","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbr.2020.112925_bib0310","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbr.2009.10.020","article-title":"Dopamine D4 receptor (D4R) deletion in mice does not affect operant responding for food or cocaine","volume":"207","author":"Thanos","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2020.112925_bib0315","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00213-008-1238-0","article-title":"Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI","volume":"203","author":"Marona-Lewicka","year":"2009","journal-title":"Psychopharmacology"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820306240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820306240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:25:14Z","timestamp":1759065914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432820306240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":63,"alternative-id":["S0166432820306240"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112925","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112925"}}